Pink SheetScripMedtech InsightHBW InsightGenerics BulletinIn Vivo

Generics Bulletin

Medtech Insight

Teva To Launch First Generic EpiPen In 'Coming Months'; FDA Heralds Approval Of Complex Product

Aug 16 2018

• By Brenda Sandburg

Related Content

Mylan Communications With CMS To Get Outside Review Under EpiPen Settlement

Aug 17 2017

EpiPen Pricing Got Mylan In Hot Water; Now Sanofi Is Taking Firm To Court

Apr 25 2017

Mylan To Explore Strategic Options, Claiming Investors Have Failed To Appreciate The Value

Aug 08 2018

Express Scripts Rewards Low List-Priced Brands In 2019 Formulary, Retains Focus On Rebates

Aug 07 2018

Mylan’s EpiPen Defense Against Generics Focuses On Device Design

Jan 22 2015

Mylan’s EpiPen Exclusivity Saved Again As Teva Reports CRL

Mar 01 2016

EpiPen Generics: Woodcock Explains Injector Studies

Sep 22 2016

Related Companies

Teva Pharmaceutical Industries Ltd.

Viatris Inc.

Express Scripts Holding Company

Amneal Pharmaceuticals, Inc.

Lineage Biomedical Inc.

Amneal Pharmaceuticals, Inc.

Merck KGaA

Sanofi

Additional Topics

United States Regulation Approvals Generic Drugs FDA BioPharmaceutical

More from Regulation

More from Policy & Regulation

Twitter feed RSS feed RSS feed

About

About UsOpens in new window
Meet the Team
Award-Winning Journalism
AdvertiseOpens in new window
Contact Us

Account

My Account
My View
Email Preferences
Start Free TrialOpens in new window

More

Generics Top 50 Ranking
Biosimilars
Generics
Value Added Medicines

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window